DHA affiliate-Joslin Diabetes Centre records over 15,500 patient visits during its first year

Key points
- Under the patronage and presence of H.E Qadhi Saeed Al Murooshid, Director General of the Dubai Health Authority, the Joslin Diabetes Center, affiliate at the Dubai Health Authority celebrated its first anniversary.
- The centre is the only dedicated multidisciplinary diabetes care and management establishment in the Emirate of Dubai.
- The Joslin Diabetes Center was established in Boston in 1898 and since then it has been a global leader in meeting the ever-changing challenges of diabetes.
- "We are proud of this centre which provides frontline treatment to manage and treat this condition.
Under the patronage and presence of H.E Qadhi Saeed Al Murooshid, Director General of the Dubai Health Authority, the Joslin Diabetes Center, affiliate at the Dubai Health Authority celebrated its first anniversary.
The centre is the only dedicated multidisciplinary diabetes care and management establishment in the Emirate of Dubai.
Located in the campus of Al Wasl Hospital, the centre was last year inaugurated by His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance and President of Dubai Health Authority with an aim of providing the people of Dubai a multi-disciplinary treatment facility to prevent and manage the disease.
The Joslin Diabetes Center was established in Boston in 1898 and since then it has been a global leader in meeting the ever-changing challenges of diabetes. The opening of this centre in Dubai last year, marked its presence in the gulf region, where diabetes is a pressing medical concern.
His Excellency Qadhi Saeed Al Murooshid, Director General of the DHA said:
"We are proud of this centre which provides frontline treatment to manage and treat this condition. The centre is unique because of its approach to managing and tackling this condition. It is our aim at the DHA, to provide specialized medical services to the people living and working in Dubai and this centre offers the very best international level of care to tackle this condition."
Dr Hamed Farooqi, M.D., Medical Director of the Joslin Diabetes Center Dubai presented the annual statistics as well as highlighted the number of visits the centre has made across government, semi-government, private entities, colleges and universities to conduct free glucose screening for the public. In addition to this, beginning next month the centre is also planning conduct lectures of diabetes care and management for the benefit of the public.
He mentioned that over the last one year, the centre has recorded more than 15, 588 patient visits. Of these, 5898, were new patient visits and 9690 were follow-up patient visits.
In terms of the clinical indicators, for the first three months of the opening of the centre, the accumulative average of the blood glucose level decrease was enough to show a 20% decrease in blindness and 30% decrease in kidney failure in the group of patients that the centre received.
The centre has also been consistently conducting screening for diabetic damage to the eyes and results showed that one in five individuals were unaware that they were already suffering from retinal damage.
Dr Farooqi said, "The Joslin Diabetes Centre is a pioneer in diabetes management and we have over the last one year brought the most advanced diabetic care to the Emirate of Dubai. We work at various levels from providing treatment to diabetics and pre-diabetics, establishing a strong referral system, training healthcare practitioners in diabetes management, promoting diabetes awareness and building unified diabetes protocols across DHA hospitals to ensure that we can not only control the incidence of diabetes but also prevent further cases."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsResearchers find a potential target for the treatment of type 2 diabetes
Currently, there are more than 350 million type 2 diabetics and according to the World Health Organization (WHO) by 2030 it will be the 7th leading cause of death worldwide. The hallmark of type 2 diabetes is insulin…
19 June 2015
NewsWhich artificial pancreas system is the best for children with type 1 diabetes?
A Montréal research team, co-supervised by Dr. Rémi Rabasa-Lhoret from the IRCM and Dr. Laurent Legault from the Montreal Children's Hospital, undertook the first paediatric outpatient study to compare three alternative…
11 June 2015
NewsA step towards a type 1 diabetes vaccine by using nanotherapy
Two years ago, the Immunology of Diabetes Research Group at the Germans Trias Research Institute (at Universitat Autònoma de Barcelona - Campus of International Excellence Sphere) reported a new experimental…






